Is Surface Oncology Inc (SURF) a Winner in the Biotechnology Industry?

Wednesday, September 06, 2023 03:59 PM | InvestorsObserver Analysts

Mentioned in this article

Is Surface Oncology Inc (SURF) a Winner in the Biotechnology Industry?

A rating of 96 puts Surface Oncology Inc (SURF) near the top of the Biotechnology industry according to InvestorsObserver. Surface Oncology Inc's score of 96 means it scores higher than 96% of stocks in the industry. Surface Oncology Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 70 out of the 148 industries.

SURF has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on SURF!

See Full SURF Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Surface Oncology Inc Stock Today?

Surface Oncology Inc (SURF) stock has risen 4.43% while the S&P 500 is down -0.7% as of 3:53 PM on Wednesday, Sep 6. SURF is up $0.04 from the previous closing price of $1.01 on volume of 656,809 shares. Over the past year the S&P 500 is up 14.25% while SURF is down -20.30%. SURF lost -$1.54 per share the over the last 12 months. Click Here to get the full Stock Report for Surface Oncology Inc stock.